Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Proteomics International Laboratories Ltd. ( (AU:PIQ) ) has issued an update.
Proteomics International Laboratories Ltd has applied to the ASX for quotation of 147,286 new fully paid ordinary shares under its ticker PIQ, effective 16 January 2026. The incremental issuance modestly expands the company’s listed share capital, potentially enhancing liquidity in its stock and reflecting ongoing exercise or conversion of existing securities by investors.
The most recent analyst rating on (AU:PIQ) stock is a Hold with a A$0.84 price target. To see the full list of analyst forecasts on Proteomics International Laboratories Ltd. stock, see the AU:PIQ Stock Forecast page.
More about Proteomics International Laboratories Ltd.
Average Trading Volume: 426,387
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$137.6M
For an in-depth examination of PIQ stock, go to TipRanks’ Overview page.

